|
시장보고서
상품코드
2077662
소비자 유전체학 시장 : 제품 및 서비스별, 용도별, 지역별Global Consumer Genomics Market, By Product and Services, By Application, By Geography |
||||||
세계의 소비자 유전체학 시장은 2026년에 22억 5,000만 달러 규모가 될 것으로 추정되며, 2033년까지 82억 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 20.3%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 22억 5,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 20.30% | 2033년 시장 규모 예측: | 82억 달러 |
소비자 대상 유전자 검사(DTC-GT)란, 타액 검체를 통해 개인의 유전 정보(일반적으로 조상, 일부 건강 특성 및 건강 위험)에 관한 정보를 제공하기 위해 소비자에게 직접 판매되는 유전자 검사를 말합니다. 현재 유전자 검사에는 주로 3가지 범주가 있습니다. 즉, 의료기관 기반 유전자 검사, 소비자 대상 유전자 검사, 그리고 의료 제공자 중개형 유전자 검사입니다. 의료기관을 통한 유전자 검사는 기존의 의료진과 환자 간의 관계를 통해, 의사 또는 기타 의료 전문가에 의해 의뢰, 분석 및 결과 공개가 이루어집니다. 의료기관을 통한 유전자 검사에서 일반적으로 취하는 접근 방식은, 검사 전 상담을 통해 잠재적인 유전적 위험 요인을 파악하고 기록한 뒤, 최적의 검사를 선택하는 동시에 검사의 장점과 한계에 대해 논의하고, 환자로부터 사전 동의를 얻도록 노력하는 것입니다. 많은 기업들이 개인의 DNA를 분석하여 유전적 배경이나 가계에 관한 정보를 제공하고 있으며, 대부분의 경우 지리적 세부 정보도 포함되어 있습니다. 일부 서비스에서는 유전적 변이를 분석하여 특정 건강 상태에 대한 소인, 특정 약물에 대한 잠재적 반응(약리유전학), 그리고 생활 습관 및 영양에 관한 제안 등의 정보를 제공하고 있습니다. 유전체 기술의 급속한 발전으로 유전자 검사가 더욱 저렴해지고 이용하기 쉬워지면서, 소비자들의 이용이 활성화되고 있습니다. 소비자들이 의료 시설을 방문하지 않고도 손쉽게 건강에 관한 정보를 얻으려 하는 가운데, 일반 소비자 대상(DTC) 유전자 검사 키트의 인기가 급상승하고 있습니다. 사람들은 잠재적인 건강 위험 요인을 파악하고 예방 조치를 취하는 데 점점 더 많은 관심을 기울이고 있으며, 그 과정에서 유전자 검사를 받는 경우가 늘어나고 있습니다.
시장 역학:
시장의 주요 업체들이 제휴 등 비유기적 성장 전략을 채택하는 사례가 증가하고 있는 것이, 예측 기간 동안의 시장 성장을 견인할 것으로 전망됩니다. 예를 들어, 2022년 1월, 미국인류유전학회(ASHG)는 'ASHG Genetics and Genomics Impact Partnerships' 프로그램의 출범을 발표했습니다. 차세대 유전체 시퀀싱 기술의 선두주자인 일루미나(Illumina)와 의료 유전학 분야를 선도하는 인비테(Invite)는 이 프로그램의 창립 파트너로 참여하고 있습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 소비자 유전체학 시장의 주요 기업 개요을 소개하고 있습니다.
- 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 소비자 유전체학 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 소비자 유전체학 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제5장 세계의 소비자 유전체학 시장 : 제품 및 서비스별, 2021-2033년
제6장 세계의 소비자 유전체학 시장 : 용도별, 2021-2033년
제7장 세계의 소비자 유전체학 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.07.08Global Consumer Genomics Market is estimated to be valued at USD 2.25 Bn in 2026 and is expected to reach USD 8.20 Bn by 2033, growing at a compound annual growth rate (CAGR) of 20.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.25 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 20.30% | 2033 Value Projection: | USD 8.20 Bn |
Direct-to-consumer genetic tests (DTC-GT) are genetic tests sold directly to consumers to provide information about their genetic information (generally ancestry, some health traits, and health risks) from a saliva sample. Three main categories of genetic testing are currently available: clinic-based, direct-to-consumer, and provider-mediated genetic testing. Clinic-based genetic testing is ordered, interpreted, and disclosed by a physician or other healthcare professional through a traditional healthcare professional-patient relationship. Standard-of-care approaches to clinic-based genetic testing involve a pre-test consultation to identify and document potential genetic risk factors, select the most appropriate test, and discuss the benefits and limitations of testing to facilitate informed consent from the patient. By analyzing an individual's DNA, companies can provide insights into genetic heritage and lineage, often with geographic detailing. Some services interpret genetic variations to provide information on predispositions to certain health conditions, potential reactions to certain drugs (pharmacogenomics), and suggestions for lifestyle or nutrition. Rapid advancements in genomics technologies have made genetic testing more affordable and accessible, encouraging consumer adoption. There has been a surge in the popularity of direct-to-consumer (DTC) genetic testing kits as consumers seek convenient health insights without visiting healthcare facilities. People are increasingly interested in identifying potential health risks and taking preventive measures, which often involves genetic testing.
Market Dynamics:
The increasing adoption of inorganic growth strategies such as partnerships by the key players in the market is expected to drive the growth of the market over the forecast period. For instance, in January 2022, the American Society of Human Genetics (ASHG) announced the launch of the ASHG Genetics and Genomics Impact Partnerships program. Illumina, a leader in next-generation genomic sequencing technologies, and Invitae, a leading medical genetics company, have joined as founding partners of ASHG Genetics and Genomics Impact Partnerships program.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global consumer genomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Ancestry, Gene By Gene, Ltd. 3andMe,Inc., Color Genomics,Inc, Myriad Genetics,Inc, Mapmygenome, Positive Biosciences, Ltd, Futura Genetics, Helix OpCo LLC, MyHeritage Ltd., Pathway Genomics, Veritas, Amgen, Inc., Xcode Life, Diagnomics, Inc., Toolbox Genomics, SomaLogic, Inc., inui Health AgeCurve, QuickCheck Health, Biomeb, Metabolomic Discoveries GmbH, Illumina, Inc., Genetic Technologies Limited
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global consumer genomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global consumer genomics market
Detailed Segmentation:
- Global Consumer Genomics Market Segmentation, By Product and Services (Revenue, USD Bn, 2021 - 2033)
- Consumables
- Systems
- Software
- Global Consumer Genomics Market Segmentation, By Application (Revenue, USD Bn, 2021 - 2033)
- Diagnostics
- Wellness and Nutrition
- Personalized Medicine
- Ancestry
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profile:
- Ancestry
- Gene By Gene, Ltd.
- 23andMe,Inc.
- Color Genomics,Inc
- Myriad Genetics,Inc
- Mapmygenome
- Positive Biosciences, Ltd
- Futura Genetics
- Helix OpCo LLC
- MyHeritage Ltd.
- Pathway Genomics
- Veritas
- Amgen, Inc.
- Xcode Life
- Diagnomics, Inc.
- Toolbox Genomics
- SomaLogic, Inc.
- inui Health
- AgeCurve
- QuickCheck Health
- Biomeb
- Metabolomic Discoveries GmbH
- Illumina, Inc.
- Genetic Technologies Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Consumer Genomics, By Product and Services
- Market Consumer Genomics, By Application
- Market Consumer Genomics, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising Interest in Personalized Healthcare
- Restraints
- Accuracy and reliability concerns
- Opportunities
- Untapped growth potential in emerging markets
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Consumer Genomics Market, By Product and Services, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
6. Global Consumer Genomics Market, By Application, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Wellness and Nutrition
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Personalized Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Ancestry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
7. Global Consumer Genomics Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 €"2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services,2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services,2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services,2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services,2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product and Services,2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application , 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Ancestry
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gene By Gene, Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- 23andMe,Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Color Genomics,Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Myriad Genetics,Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mapmygenome
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Positive Biosciences, Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Futura Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Helix OpCo LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MyHeritage Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pathway Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Veritas
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Amgen, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Xcode Life
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Diagnomics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Toolbox Genomics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SomaLogic, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- inui Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AgeCurve
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- QuickCheck Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biomeb
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Metabolomic Discoveries GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Illumina, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Genetic Technologies Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
